Cresset Asset Management, LLC Applied Therapeutics Inc. Transaction History
Cresset Asset Management, LLC
- $21.3 Billion
- Q3 2025
A detailed history of Cresset Asset Management, LLC transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Cresset Asset Management, LLC holds 17,091 shares of APLT stock, worth $15,723. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,091Holding current value
$15,723% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding APLT
# of Institutions
78Shares Held
92.5MCall Options Held
152KPut Options Held
186K-
T. Rowe Price Investment Management, Inc. Baltimore, MD18.7MShares$17.2 Million0.0% of portfolio
-
Vestal Point Capital, LP New York, NY11.5MShares$10.6 Million0.19% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA11.3MShares$10.4 Million6.83% of portfolio
-
Knoll Capital Management, LLC Miami, FL7.8MShares$7.18 Million1.64% of portfolio
-
Black Rock Inc. New York, NY6.57MShares$6.04 Million0.0% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $44.2M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...